When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALBO - Albireo expects late-stage data on odevixibat mid-2020
Albireo Pharma Inc.
In an update for investors, Albireo Pharma (NASDAQ:ALBO) announces that enrollment in its Phase 3 clinical trial, PEDFIC 1, evaluating odevixibat in pediatric patients with progressive familial intrahepatic cholestasis (PFIC) is over 50% completed.
More news on: Albireo Pharma, Inc., Healthcare stocks news,